Polycystic ovary syndrome was renamed to polyendocrine metabolic ovarian syndrome to better represent the condition and its symptoms, UCLA health professionals said.
Scientists announced the name change May 12 at the European Congress of Endocrinology in Prague, and the American Society for Reproductive Medicine endorsed the switch to PMOS May 27.

This post was updated Sept. 7 at 8:33 p.m.
Federal funding cuts and tight budgets will lead to fewer opportunities for undergraduates looking to do research in UCLA labs.